| 000 | 00909 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517164311.0 | ||
| 264 | 0 | _c20180124 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1527-3350 | ||
| 024 | 7 |
_a10.1002/hep.29394 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSauerbruch, Tilman | |
| 245 | 0 | 0 |
_aContinuation of nonselective beta-blockers for patients with liver cirrhosis and hemodynamic nonresponse? _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _c10 2017 |
||
| 300 |
_a1362-1363 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAdrenergic beta-Antagonists |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypertension, Portal |
| 650 | 0 | 4 | _aLiver Cirrhosis |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 66 _gno. 4 _gp. 1362-1363 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.29394 _zAvailable from publisher's website |
| 999 |
_c27393129 _d27393129 |
||